NEO

DeFi Technologies’ Wholly-Owned Subsidiary Valour Inc., Bitcoin Suisse AG, and STOXX Launch the 1Valour STOXX Bitcoin Suisse Digital Asset Blue Chip ETP

Retrieved on: 
Monday, March 18, 2024
Bitcoin, Crypto, ETP, NEO, Exchange-traded product, Partnership, Classification, Digital, GCT, Decentralized finance, OTC, Index, Cryptocurrency, Culture

Launch of 1Valour STOXX Bitcoin Suisse Digital Asset Blue Chip ETP: DeFi Technologies Inc. announces a collaborative product from Valour Inc., Bitcoin Suisse AG, and STOXX, offering a diversified investment in top blue-chip digital assets through a new Exchange Traded Product (ETP).

Key Points: 
  • Launch of 1Valour STOXX Bitcoin Suisse Digital Asset Blue Chip ETP: DeFi Technologies Inc. announces a collaborative product from Valour Inc., Bitcoin Suisse AG, and STOXX, offering a diversified investment in top blue-chip digital assets through a new Exchange Traded Product (ETP).
  • Innovative Methodology and Partnerships: The ETP, tracking the STOXX Digital Asset Blue Chip X Index, is based on a rule-based passive index methodology, leveraging Bitcoin Suisse's Global Crypto Taxonomy for asset classification.
  • We are proud to collaborate with well established and trusted partners in the global financial markets for the launch of this innovative product.“
    The 1Valour STOXX Bitcoin Suisse Digital Asset Blue Chip ETP is uniquely structured to track the performance of the STOXX Digital Asset Blue Chip X Index.
  • This ETP is the result of a synergistic collaboration between Valour, Bitcoin Suisse, and STOXX, each bringing unique strengths to the table.

Mount Logan Capital Inc. Announces Fourth Quarter and Fiscal 2023 Financial Results

Retrieved on: 
Thursday, March 14, 2024
Sentinel, NEO, CLO, American Express, Income Tax Act, PwC, Growth, MLC, Insurance, EPS, Business, Acquisition, University, Galaxy Digital, Commerce, TSX, Investment, Silicon, Silicon Valley Bank, Policy, Corporation, Cryptocurrency

TORONTO, March 14, 2024 (GLOBE NEWSWIRE) -- Mount Logan Capital Inc. (NEO: MLC) (the “Company” or “Mount Logan”) announced today its financial results for the fourth quarter and fiscal year ended December 31, 2023. All amounts are stated in United States dollars, unless otherwise indicated. The financial results have been adjusted for the adoption of IFRS 17 Insurance Contracts (“IFRS 17”) which became effective January 1, 2023.

Key Points: 
  • The financial results have been adjusted for the adoption of IFRS 17 Insurance Contracts (“IFRS 17”) which became effective January 1, 2023.
  • Fourth quarter asset management revenues excludes $1.3 million of management fees associated with Mount Logan’s management of the assets of Ability Insurance Company (“Ability”), a wholly-owned subsidiary of the Company, during the fourth quarter of 2023, which increased by 82% as compared to the fourth quarter 2022 of $0.7 million.
  • Ability’s total assets managed by Mount Logan increased to $537.1 million for fiscal 2023, up $200.2 million from fiscal 2022 managed assets of $336.9 million.
  • Adjusted basic EPS was $(0.44) for the 2023 fiscal year, a decrease of $(2.74) from $2.30 for the 2022 fiscal year.

Technology Advancement: NEO Battery Expands Production Yield and Capacity with Manufacturing Innovation

Retrieved on: 
Thursday, March 14, 2024
NEO, Solvent, Certified Public Accountant, Particle size, BYD, Honda Rafaga, Original equipment manufacturer, History, Silicon, OEM, Samsung, Patent, Public sector, LG Energy Solution, CATL, Hyundai Motor Group, CPA, Electric battery

TORONTO, March 14, 2024 (GLOBE NEWSWIRE) -- (TSXV: NBM) (OTCQB: NBMFF)

Key Points: 
  • TORONTO, March 14, 2024 (GLOBE NEWSWIRE) -- (TSXV: NBM) (OTCQB: NBMFF)
    Major Process Innovation Improves Silicon Anode Yield, Capacity, and Particle Uniformity
    NEO Battery Materials Ltd. (“NEO” or the “Company”), a low-cost silicon anode materials developer that enables longer-running, rapid-charging lithium-ion batteries, is pleased to report technological advancements in NEO Battery’s silicon anode production yield, capacity, and quality through its recent manufacturing innovation.
  • During NBMSiDE® manufacturing, special additives effectively prevent silicon particle clustering or agglomeration by acting as an interparticle buffer layer.
  • By developing similar innovations, NEO Battery Materials aims to become a leader in the silicon anode market by securing price competitiveness through increased production yield and improving particle size uniformity and product quality.
  • This innovation is significant as no additional equipment or process changes are required to improve NEO’s One-Step Production Process.

TILT Holdings Announces New Brand Partnership with LEVEL to Bring Their Cannabis Tablets to Pennsylvania

Retrieved on: 
Wednesday, March 13, 2024
NEO, Partnership, Sativum, Patient, Tablet, LEVEL, Life, TILT, THC, Pharmaceutical industry

PHOENIX, March 13, 2024 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT” or the “Company”) (NEO: TILT ) (OTCQB: TLLTF ), a global provider of cannabis business solutions including inhalation technologies, cultivation, manufacturing, processing, brand development and retail, today announced a new brand partnership to distribute LEVEL ’s targeted, effects-based infused tablets to patients in Pennsylvania.

Key Points: 
  • PHOENIX, March 13, 2024 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT” or the “Company”) (NEO: TILT ) (OTCQB: TLLTF ), a global provider of cannabis business solutions including inhalation technologies, cultivation, manufacturing, processing, brand development and retail, today announced a new brand partnership to distribute LEVEL ’s targeted, effects-based infused tablets to patients in Pennsylvania.
  • “Partnering with LEVEL to bring their products to market in Pennsylvania expands TILT’s offerings in a meaningful way for medical patients.
  • We love that these oral tablets are portable, discreet, and allow for dialed-in dosing.” said Tim Conder, Chief Executive Officer of TILT.
  • Together, TILT and LEVEL are opening doors to forge new possibilities for medical cannabis consumers.”
    “LEVEL is thrilled to bring a best-in-class, highly effective, long-lasting tablet to Pennsylvania through our partnership with TILT.

The Cannabist Company to Report First Quarter 2024 Results on May 9, 2024

Retrieved on: 
Wednesday, March 27, 2024
Pharmaceutical, Health, Natural Resources, Cannabis, NEO, Telephone, EDT

The Cannabist Company Holdings Inc. (NEO: CBST) (OTCQX: CBSTF) (FSE: 3LP) (“The Cannabist Company” or the “Company”), today announced that it will report its financial results for the first quarter ended March 31, 2024 before U.S. financial markets open on Thursday, May 9, 2024.

Key Points: 
  • The Cannabist Company Holdings Inc. (NEO: CBST) (OTCQX: CBSTF) (FSE: 3LP) (“The Cannabist Company” or the “Company”), today announced that it will report its financial results for the first quarter ended March 31, 2024 before U.S. financial markets open on Thursday, May 9, 2024.
  • Following the release of financial results, Company management will conduct a conference call at 8:00 a.m. EDT to discuss financial and operating results for the first quarter of 2024.
  • After registering, instructions will be shared on how to join the call for those who wish to dial in.
  • A live audio webcast of the call will also be available in the Investor Relations section of the Company's website at https://investors.cannabistcompany.com/ or at https://edge.media-server.com/mmc/p/ccsxarjo .

NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting

Retrieved on: 
Wednesday, March 27, 2024
Science, Biotechnology, Research, Pharmaceutical, Oncology, General Health, Health, Clinical Trials, NEO, Patient, Tumor microenvironment, Cancer, Abstract, AACR, Clinical trial, Annual general meeting, Medical imaging

NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, alongside research collaborators, will present key findings from 11 abstracts at the American Association for Cancer Research (AACR) 2024 Annual Meeting in San Diego, April 5-10 (booth #915), demonstrating its commitment to advancing cancer patient care through innovative research and development initiatives.

Key Points: 
  • NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, alongside research collaborators, will present key findings from 11 abstracts at the American Association for Cancer Research (AACR) 2024 Annual Meeting in San Diego, April 5-10 (booth #915), demonstrating its commitment to advancing cancer patient care through innovative research and development initiatives.
  • The breadth of data highlights NeoGenomics’ comprehensive approach to addressing various aspects of cancer diagnosis, treatment, and management.
  • “Our presence at the AACR 2024 Annual Meeting reflects our dedication and investment in advancing the field of precision oncology through groundbreaking research and collaborative partnerships," said Chris Smith, CEO of NeoGenomics.
  • By leveraging genomic and molecular analysis, NeoGenomics empowers healthcare providers with actionable insights to tailor treatment strategies and enhance patient outcomes.

NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report

Retrieved on: 
Wednesday, March 20, 2024
Medical Devices, Professional Services, Science, Genetics, DEI (Diversity, Equity and Inclusion), Clinical Trials, Biotechnology, Health, Health Technology, Recycling, Research, Sustainability, Environmental, Social and Governance (ESG), Environment, Radiology, Pharmaceutical, Oncology, NEO, Development, Growth, ESG, Patient, Environmental stewardship, Cancer, Business ethics, Woman, Workforce, Retention, Consumer, Management

This inaugural report details the performance and management of NeoGenomics’ commitment to its core values of quality, integrity, accountability, teamwork, and innovation.

Key Points: 
  • This inaugural report details the performance and management of NeoGenomics’ commitment to its core values of quality, integrity, accountability, teamwork, and innovation.
  • “Releasing our first ESG report marks an important milestone in NeoGenomics’ growth and evolution,” said Chris Smith, CEO at NeoGenomics.
  • In 2023, NeoGenomics recycled 310 tons of waste from its labs in Fort Myers, FL, and Aliso Viejo, CA.
  • NeoGenomics’ 2023 Employee Engagement Survey showed net improvements in Employee Happiness and Employee Engagement and decreased voluntary employee turnover to 13%.

Pyramid Global Hospitality Ignites 2024 with an Expansion in Iconic Locales from Sandy Beaches to Sundance

Retrieved on: 
Tuesday, April 2, 2024
NEO, Culture, Conference, Growth, Pyramid, Collection

Pyramid Global Hospitality – the powerhouse hospitality company behind inspired collections like Benchmark Pyramid Luxury & Lifestyle and Hamilton Pyramid Europe –welcomes nine properties to its U.S. portfolio.

Key Points: 
  • Pyramid Global Hospitality – the powerhouse hospitality company behind inspired collections like Benchmark Pyramid Luxury & Lifestyle and Hamilton Pyramid Europe –welcomes nine properties to its U.S. portfolio.
  • In Florida, property additions include Naples Grande Beach Resort, Saddlebrook Resort Tampa and Hotel Flor, a Tapestry Collection Hotel by Hilton.
  • Iconic boutique resorts to join the collection include Black Rock Mountain Resort in Utah, Wayfinder Waikiki in Hawaii, and Wayfinder Bishop Creekside Inn in California.
  • "2024 is off to a momentous start as we continue toward our overall goal of being the Manager of Choice in our industry," said Warren Fields, CEO of Pyramid Global Hospitality.

DeFi Technologies Inc. Announces 2023 Financial Results: Revenues Exceed C$10.4 Million, Notable Strategic Developments and Restatement of Fiscal 2022 Financial Results

Retrieved on: 
Tuesday, April 2, 2024
XRP, ETP, NEO, Financial management, Genesis, Growth, Projection, Consultation, ICP, The Company, Acquisition, CPAB, Yoy, Investment, AUM, IP, OTC, Ecosystem, USD, Fiscal, Cryptocurrency

Total revenues were $10.4 million for the twelve months ended December 31, 2023 ("Fiscal 2023").

Key Points: 
  • Total revenues were $10.4 million for the twelve months ended December 31, 2023 ("Fiscal 2023").
  • A significant improvement from the revenues of $(14.2) million for the twelve months ended December 31, 2022 ("Fiscal 2022").
  • Operating, general, and administration costs for Fiscal 2023 was $10 million, down from $14.7 million in Fiscal 2022.
  • "We are pleased to have completed the audit for Fiscal 2023 and the restatement of the Fiscal 2022 statement of the Company," said Ryan Ptolemy, Chief Financial Officer of the Company.

DeFi Technologies Announces Shareholder Call to Discuss Q4 2023 Financial Results

Retrieved on: 
Friday, March 29, 2024
NEO, EST, The Company, OTC

TORONTO, March 28, 2024 /PRNewswire/ - DeFi Technologies Inc. (the "Company" or "DEFI") (NEO: DEFI) (GR: R9B) (OTC: DEFTF), a financial technology company and the first and only publicly traded company that bridges the gap between traditional capital markets, Web3 and decentralised finance,today announces it will conduct a shareholder call on Thursday, April  4, 2024 at 1:00 p.m. EST to discuss its financial performance for the twelve-month period ending December 31, 2023.

Key Points: 
  • TORONTO, March 28, 2024 /PRNewswire/ - DeFi Technologies Inc. (the "Company" or "DEFI") (NEO: DEFI) (GR: R9B) (OTC: DEFTF), a financial technology company and the first and only publicly traded company that bridges the gap between traditional capital markets, Web3 and decentralised finance,today announces it will conduct a shareholder call on Thursday, April  4, 2024 at 1:00 p.m. EST to discuss its financial performance for the twelve-month period ending December 31, 2023.
  • The Company's 2023 financials will be available after market close on April 1, 2024.
  • IMPORTANT – To register for the webcast see below: